Design of mitochondria-targeting nanocomposites for enhanced catalytic cascade in multimodal tumor therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Angiogenic signaling pathways and anti-angiogenic therapy for cancer10.1038/s41392-023-01460-1 ↗
2. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer10.7150/thno.89805 ↗
3. Enhancing global access to cancer medicines
4. Dual starvations induce pyroptosis for orthotopic pancreatic cancer therapy through simultaneous deprivation of glucose and glutamine10.1021/jacs.4c03478 ↗
5. Molecular photoswitching unlocks glucose oxidase for synergistically reinforcing fenton reactions for antitumor chemodynamic therapy
6. A needle‐like H2S‐releasing and H2O2 self‐replenishing nanoplatform for enhanced chemodynamic tumor immunotherapy
7. A multifunctional cascade gas-nanoreactor with MnO2 as a gatekeeper to enhance starvation therapy and provoke antitumor immune response10.1016/j.actbio.2024.11.004 ↗
8. Glucose oxidase and metal catalysts combined tumor synergistic therapy: mechanism, advance and nanodelivery system10.1186/s12951-023-02158-w ↗
9. Stereotactic body radiation therapy alone or in combination with immunotherapy in kidney cancer: a systematic review10.1016/j.eururo.2025.03.016 ↗
10. Advances in photoactivated carbon-based nanostructured materials for targeted cancer therapy10.1016/j.addr.2025.115604 ↗
11. Advances in cancer immunotherapy: historical perspectives, current developments, and future directions10.1186/s12943-025-02305-x ↗
12. Alginate-functionalized and 4T1 cell membrane-coated multi-tasking nanoparticulate system for near-infrared-triggered photodynamic therapy on breast cancer: in vitro cellular and in vivo mice models10.1016/j.coco.2024.102066 ↗
13. Multi‐enzyme mimetic mocu dual‐atom nanozyme triggering oxidative stress cascade amplification for high‐efficiency synergistic cancer therapy
14. A forward vision for chemodynamic therapy: issues and opportunities
15. Strategies to engineer various nanocarrier-based hybrid catalysts for enhanced chemodynamic cancer therapy10.1039/D3CS00356F ↗
16. Metal-phenolic-network-coated gold nanoclusters for enhanced photothermal/chemodynamic/immunogenic cancer therapy
17. Current progress in the regulation of endogenous molecules for enhanced chemodynamic therapy10.1039/D4SC02129K ↗
18. Folic acid functionalization of rgo/co3o4/chitosan based biocompatible nanocomposite enhances targeted delivery and cytotoxicity of doxorubicin10.1016/j.coco.2025.102362 ↗
19. Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment
20. Mitosiege‐driven catalase collapse: a GSH‐responsive, mitochondria‐targeted COF prodrug for amplified chemodynamic therapy
21. Near-infrared-triggered release of self-accelerating cascade nanoreactor delivered by macrophages for synergistic tumor photothermal therapy/starvation therapy/chemodynamic therapy10.1016/j.jcis.2025.01.161 ↗
22. Ros scavenging carbon dots chelated hydroxyapatite filler: target synthesis and enhancing adhesion of hydrogel10.1016/j.coco.2022.101488 ↗
23. Tumor microenvironment-activated in situ synthesis of peroxynitrite for enhanced chemodynamic therapy10.1021/acsnano.4c10012 ↗
24. Biomimetic yolk–shell nanocatalysts for activatable dual-modal-image-guided triple-augmented chemodynamic therapy of cancer10.1021/acsnano.2c08077 ↗
25. “Three‐in‐one” nanozyme composite for augmented cascade catalytic tumor therapy
26. Bimetallic nanoreactor mediates cascade amplification of oxidative stress for complementary chemodynamic-immunotherapy of tumor10.1016/j.biomaterials.2024.123075 ↗
27. “All‐in‐one” MnO2 @PtAuRu nanoreactor for self‐replenishing and cascade catalytic therapy of cancer
28. Jahn–teller-driven electronic modulation of bio-heterojunction for wound regeneration after postoperative tumor resection10.1021/acs.nanolett.5c01632 ↗
29. Glucose oxidase-instructed traceable self-oxygenation/hyperthermia dually enhanced cancer starvation therapy10.7150/thno.40439 ↗
30. Synthesis and integration of sea urchin-like MnO2-GCN nanocomposite with imprinted polymers for mass-sensitive detection of chloramphenicol in water10.1016/j.coco.2025.102357 ↗
31. Flower-like MnO2 nanoparticles modified thin film nanocomposite membranes for efficient organic solvent nanofiltration10.1016/j.coco.2023.101515 ↗
32. CDK4 inactivation inhibits apoptosis via mitochondria-ER contact remodeling in triple-negative breast cancer10.1038/s41467-024-55605-z ↗
33. Intranuclear tca and mitochondrial overload: the nascent sprout of tumors metabolism10.1016/j.canlet.2025.217527 ↗
34. A mitochondria‐targeted biomimetic nanomedicine capable of reversing drug resistance in colorectal cancer through mitochondrial dysfunction10.4028/b-XDTcg5 ↗
35. MMP-2-triggered, mitochondria-targeted protac-pdt therapy of breast cancer and brain metastases inhibition10.1038/s41467-024-54854-2 ↗
36. Mitochondria‐targeted molecular tools in precise tumor therapy
37. Albumins constrainting the conformation of mitochondria-targeted photosensitizers for tumor-specific photodynamic therapy10.1016/j.biomaterials.2024.122914 ↗
38. Mitochondria-targeting pseudo-stealthy nanophotosensitizer as a potent immunogenic cell death inducer to unleash the cancer-immunity cycle for melanoma therapy10.1016/j.actbio.2025.07.035 ↗
39. Green-light-triggered and self-calibrated cascade release of nitric oxide and carbon monoxide for synergistic glaucoma therapy10.1021/jacs.4c10457 ↗
40. Antibacterial gas therapy: strategies, advances, and prospects
41. Dual-mode reactive oxygen species-stimulated carbon monoxide release for synergistic photodynamic and gas tumor therapy10.1021/acsnano.4c10277 ↗
42. Red light-induced localized release of carbon monoxide for alleviating postoperative cognitive dysfunction10.1016/j.biomaterials.2024.122744 ↗
43. Inhibiting glycolysis and disrupting the mitochondrial HK2–VDAC1 protein–protein interaction using a bifunctional lonidamine-conjugated metal probe for combating triple-negative breast cancer10.1021/jacs.5c04233 ↗
44. Oral carbon monoxide enhances autophagy modulation in prostate, pancreatic, and lung cancers10.1002/advs.202308346 ↗
45. Carbon monoxide-releasing nanomotors based on endogenous biochemical reactions for tumor therapy10.1016/j.jcis.2024.02.135 ↗
46. Photocatalytic co-releasing spray hydrogel for in situ postoperative cancer treatment
47. NIR-II light-activated gold nanocapsules for co-assisted photothermal–thermodynamic synergistic cancer therapy10.1021/acsami.5c00919 ↗
48. Cancer cell membrane biomimetic composites of cisplatin prodrug for targeted eradication of circulating tumor cells in whole blood10.1016/j.coco.2024.101882 ↗
49. H2O2 ‐responsive NIR-II AIE nanobomb for carbon monoxide boosting low‐temperature photothermal therapy10.1002/anie.202207213 ↗
50. H2S‐responsive NIR-II fluorescent nanozyme that regulates tumor microenvironment for activatable synergistic co therapy/catalytic therapy/immunotherapy10.1002/smll.202402904 ↗
51. De novo strategy of organic semiconducting polymer brushes for NIR-II light-triggered carbon monoxide release to boost deep-tissue cancer phototheranostics10.1186/s12951-024-02984-6 ↗